Complete Care, Inc. – Trademark Portfolio
Entity Type: 03
Complete Care, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include CAREBILL and COMPLETECARE INCORPORATED. The owner is based in Little Rock, AR.
1315 E. 26th Street
Little Rock, AR 72206
Showing of trademarks Trademarks
Trademark Classifications
Complete Care, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Complete Care, Inc. have?
Complete Care, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 2 abandoned, 2 cancelled.
What trademark classes does Complete Care, Inc. file in?
Complete Care, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Complete Care, Inc.'s most well-known trademarks?
Complete Care, Inc.'s registered trademark portfolio includes well-known marks such as CAREBILL and COMPLETECARE INCORPORATED. These are among 2 currently registered trademarks in the portfolio.
What is Complete Care, Inc.'s trademark registration success rate?
Complete Care, Inc. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 1 application is pending review.